This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Legend Biotech Ireland Limited. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations by Xiaojie Tu in Cancer Treatment
Introduction
Xiaojie Tu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of single-domain antibodies.
Latest Patents
Xiaojie Tu holds a patent for "Single-domain antibodies against CLL1 and constructs thereof." This patent includes single-domain antibodies targeting CLL1, along with constructs such as chimeric receptors, immune effector cell engagers, and immunoconjugates. The patent also describes engineered immune effector cells, including T cells, that comprise an anti-CLL1 chimeric receptor. Additionally, it provides pharmaceutical compositions, kits, and methods for treating cancer.
Career Highlights
Xiaojie Tu is currently employed at Legend Biotech Ireland Limited, where he continues to advance his research in immunotherapy. His work focuses on developing innovative solutions for cancer treatment, particularly through the use of engineered immune cells.
Collaborations
Xiaojie Tu collaborates with esteemed colleagues, including Wang Zhang and Yunlei Liu, to further enhance the impact of their research in the field of cancer therapy.
Conclusion
Xiaojie Tu's contributions to cancer treatment through his innovative patents and collaborative efforts highlight his importance in the field of biotechnology. His work continues to pave the way for new therapeutic approaches in combating cancer.